Skip to content
★ Sign in to follow
KYORIN Pharmaceutical Co., Ltd. logo

KYORIN Pharmaceutical Co., Ltd. Stock: price and insider trades · Japan

杏林製薬株式会社

JP·Mcap JP¥64.6BHealth Care

KYORIN Pharmaceutical Co., Ltd.: what insiders have been doing

KYORIN Pharmaceutical Co., Ltd., founded in 1940, is a Health Care company based in Tokyo, Japan. Its directors and officers file their transactions with EDINET (Japan FSA). 4 insiders have disclosed 6 filings since 27 October 2025.

No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.

No insider has bought KYORIN Pharmaceutical Co., Ltd. shares on the open market in the past twelve months. Filings reach the EDINET (Japan FSA) feed a median of 6 days after the trade. That lag is the time during which only the insider knows about the trade.

With 6 filings in twelve months, the company is more active than the median of 3 filings across the 3,207 companies we follow on the same exchange.

For comparison within the same sector, see the insider buying recorded at Dynavox Group AB and EssilorLuxottica. Every figure here comes from the filings published by EDINET (Japan FSA) and describes the past, not future prices; it is not investment advice.

Key facts

Headquarters: Tokyo, Japan · Founded: 1940

Source: Wikidata (CC0).

Insider Decl.
14
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Fundamental score
Ranked 12,615 of 26,911 companies
53.1
score / 100
Value
62
Quality
44
FCF yld3.9%
Earn yld5.5%
EV/EBITDA9.2x
ROE1.6%
Gross mgn41%
Net mgn2.7%
Debt/EBITDA2.5x
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2026

FY ended March 2026 · cache

JP¥1,125
Analyst consensus
1 analysts
4.00/5
JP¥1,100Target JP¥1,100(-2%)JP¥1,100
Income statement
RevenueJP¥126.3B
Gross profitJP¥51.6B41% margin
EBITDAJP¥9.4B7% margin
Net incomeJP¥3.4B1.7% margin
Valuation
PER (trailing)29.8x
P/Book0.5x
Beta-0.02
Balance sheet & cash
Market capJP¥64.6B
Total debtJP¥23.8B
Free Cash FlowJP¥2.4B
Debt / Equity17%
Profitability & ownership
ROE1.6%
ROA0.7%
% insiders35.8%
% institutions21.8%
Last declaration on 27 October 2026
Declarations14 total

14 of 14 declarations

About KYORIN Pharmaceutical Co., Ltd.

杏林製薬株式会社 is a Japanese company specializing in the health and pharmaceutical sector. It is listed on the XTKS market.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations